Boswellia

Common Names: boswellia, boswellia serrata, boswella, boswellin serrata resin, frankincense
Latin Names: Boswellia serrata
Background
- Boswellia serrata is a branching tree native to the mountainous regions of Northern Africa, India, and the Middle East.
- Boswellia is an herbal extract made from the gum resin or bark of the tree and can be taken orally or applied topically.
- Traditionally, boswellia has been used in Ayurveda practices to improve arthritis, reduce inflammation and pain, and relieve symptoms of some respiratory and cardiovascular diseases and other disorders.
- Boswellia extracts are sold as dietary supplements to reduce inflammation and to support joint health, mobility, and digestive health.
- The resin from the bark of Boswellia serrata or other Boswellia species is the source of frankincense, which is often inhaled for aromatherapy or applied topically.
How Much Do We Know?
- There have been several studies on the potential health benefits and safety of using boswellia, but most of these are small and of low quality. There is not enough high-quality evidence to determine whether boswellia is useful for any health condition.
What Have We Learned?
- Several studies have shown taking boswellia orally may help reduce inflammation and pain associated with osteoarthritis, but larger, higher quality studies are needed.
- The topical use of boswellia (frankincense) for osteoarthritis, rheumatoid arthritis, and other health conditions has been studied, but there isn’t enough evidence to show that it is an effective treatment.
- A few small studies suggest that taking boswellia orally may reduce asthma symptoms. However, there is not enough rigorous evidence to determine whether boswellia is a useful treatment for asthma.
- There has been limited research in people on taking boswellia orally for several types of cancer, and although some results are encouraging, larger clinical studies are needed. A small study of patients with malignant glioma, an aggressive brain tumor, showed that boswellia taken orally may help to reduce edema (swelling) of the brain but not the tumor.
- There is no evidence that boswellia can prevent or treat COVID-19.
What Do We Know About Safety?
- Boswellia is likely to be safe when taken orally. Boswellia serrata extract in doses up to 1,000 mg daily has been safely used in several clinical trials lasting up to 6 months. It has also been used with apparent safety at a dose of 2,400 mg for up to 1 month.
- Boswellia (frankincense) may be safe to use topically or for aromatherapy.
- If you have asthma, follow your health care provider’s recommendations on how to manage your condition. For your safety:
- Do not substitute other approaches for treatments recommended or prescribed by your health care provider.
- Consult your health care provider about adding any complementary health products or practices to your asthma management program. If you take medicine for asthma, talk with your provider before starting to take a dietary supplement. Some dietary supplements and medicines can interact in harmful ways.
- No complementary approach has been shown to cure cancer or cause it to go into remission. Some products or practices that have been advocated for cancer treatment may interfere with conventional cancer treatments or have other risks. If you’ve been diagnosed with cancer, you should consult your health care providers before using any complementary health approach.
- It is likely safe to use boswellia in amounts commonly found in foods during pregnancy or while breastfeeding. Little is known about whether it’s safe to use boswellia orally in medicinal amounts or to use frankincense during pregnancy or while breastfeeding.
Keep in Mind
- Take charge of your health—talk with your health care providers about any complementary health approaches you use. Together, you can make shared, well-informed decisions.
- If you take any type of medicine, talk with your health care provider before using any herbal product; some herbs and medicines interact in harmful ways.
- Federal Regulation of Herbal Products
- Depending on what’s in them, how they’re intended to be used, and how they’re administered (orally or topically), herbal products are regulated in a variety of ways. Many herbal products intended for oral use are marketed as dietary supplements. The regulatory paths for making and distributing dietary supplements are different than those for drugs.
- Unlike drugs, dietary supplements are not approved by the U.S. Food and Drug Administration (FDA) before they are sold to the public. When public health concerns arise about the safety of a dietary supplement or an ingredient including an herb, the FDA can take action to protect the public. Manufacturers and distributors of supplements are responsible for evaluating the safety and labeling of their products before marketing to ensure that they meet all regulatory requirements.
NCCIH Clearinghouse
The NCCIH Clearinghouse provides information on NCCIH and complementary and integrative health approaches, including publications and searches of Federal databases of scientific and medical literature. The Clearinghouse does not provide medical advice, treatment recommendations, or referrals to practitioners.
Toll-free in the U.S.: 1-888-644-6226
Telecommunications relay service (TRS): 7-1-1
Website: https://www.nccih.nih.gov
Email: info@nccih.nih.gov (link sends email)
PubMed®
A service of the National Library of Medicine, PubMed® contains publication information and (in most cases) brief summaries of articles from scientific and medical journals. For guidance from NCCIH on using PubMed, see How To Find Information About Complementary Health Practices on PubMed.
Website: https://pubmed.ncbi.nlm.nih.gov/
Office of Dietary Supplements (ODS), National Institutes of Health (NIH)
ODS seeks to strengthen knowledge and understanding of dietary supplements by evaluating scientific information, supporting research, sharing research results, and educating the public. Its resources include publications (such as Dietary Supplements: What You Need To Know) and fact sheets on a variety of specific supplement ingredients and products (such as vitamin D and multivitamin/mineral supplements).
Website: https://ods.od.nih.gov
Email: ods@nih.gov (link sends email)
Key References
- Bannuru RR, Osani MC, Al-Eid F, et al. Efficacy of curcumin and boswellia for knee osteoarthritis: systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 2018;48(3):416-429.
- Boswellia serrata. NatMed Pro website. Accessed at naturalmedicines.therapeuticresearch.com on April 2, 2024. [Database subscription].
- Clark CE, Arnold E, Lasserson TJ, et al. Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Primary Care Respiratory Journal. 2010;19(4):307-314.
- Dubey V, Kheni D, Sureja V. Efficacy evaluation of standardized Boswellia serrata extract (AflapinⓇ) in osteoarthritis: a systematic review and sub-group meta-analysis study. Explore (NY). 2024;20(5):102983.
- Efferth T, Oesch F. Anti-inflammatory and anti-cancer activities of frankincense: targets, treatments and toxicities. Seminars in Cancer Biology. 2022;80:39-57.
- Frankincense. NatMed Pro website. Accessed at naturalmedicines.therapeuticresearch.com on April 2, 2024. [Database subscription].
- Kirste S, Treier M, Wehrle SJ, et al. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer. 2011;117(16):3788-3795.
- Liu X, Machado GC, Eyles JP, et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. British Journal of Sports Medicine. 2018;52(3):167-175.
- Siddiqui MZ. Boswellia serrata, a potential anti-inflammatory agent: an overview. Indian Journal of Pharmaceutical Sciences. 2011;73(3):255-61.
This publication is not copyrighted and is in the public domain. Duplication is encouraged.
NCCIH has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by NCCIH.